PINNA, ANNALISA
 Distribuzione geografica
Continente #
AS - Asia 10
EU - Europa 3
NA - Nord America 1
Totale 14
Nazione #
SG - Singapore 8
IT - Italia 2
JP - Giappone 1
KR - Corea 1
SE - Svezia 1
US - Stati Uniti d'America 1
Totale 14
Città #
Rome 2
Singapore 2
Forest City 1
Seoul 1
Tokyo 1
Totale 7
Nome #
Characterization of Nasco grape pomace-loaded nutriosomes and their neuroprotective effects in the MPTP mouse model of Parkinson's disease 2
Modulatory role of adenosine A(2A) receptors in basal ganglia as basis for the use of A(2A) antagonists in the treatment of Parkinson's disease 1
RECEPTOR ANTAGONISTS IMPROVE AKINESIA AND SENSORY-MOTOR DEFICITS IN THE 6-HYDROXYDOPAMINE MODEL OF PARKINSON S DISEASE 1
INDUCTION OF FOS-LIKE IMMUNOREACTIVITY IN THE CENTRAL EXTENDED AMYGDALA BY ANTIDEPRESSANT DRUGS 1
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 1
Neuroinflammation and activation of Zif-268 in dyskinetic 6-OHDA-lesioned rats is counteracted by association of a 5-HT1A/1B receptor agonist and an A(2A) receptor antagonist 1
MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA pretreated mice 1
Adenosine A2A receptor antagonists and Parkinson's disease: state of the art and future directions 1
Fos expression induced by olanzapine and risperidone in the central extended amygdala 1
Comparative study of the influence of the acute administration of drugs of abuse on 50-kHz 1
DOPAMINE AND ADENOSINE RECEPTOR INTERACTION AS BASIS FOR THE TREATMENT OF PARKINSON S DISEASE 1
MODULATION BY ADENOSINE A2A RECEPTORS OF DOPAMINE-MEDIATED MOTOR BEHAVIOR AS A BASIS FOR ANTIPARKINSON'S DISEASE DRUGS 1
MODULATORY ROLE OF ADENOSINE A2A RECEPTORS AS BASIS FOR THE USE OF A2A ANTAGONISTS IN THE TREATMENT OF PARKINSON S DISEASE 1
Totale 14
Categoria #
all - tutte 1.545
article - articoli 862
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 143
Totale 2.550


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20244 0 0 0 0 0 0 0 0 2 0 1 1
2024/202510 6 4 0 0 0 0 0 0 0 0 0 0
Totale 14